(firstQuint)The Use of DPP-4 Inhibitors in Short Bowel Syndrome.

 The only effective (to some extend drug) in short bowel syndrome is Glucacone-like peptide 4.

 Its price is, however, to high to really change the treatment strategy for intestinal failure.

 The Dipeptidyl peptidase-4 inhibitor, which a drug which is commonly used in the treatment of diabetes mellitus type II, should increase the concentration of glucagone-like peptide 1 and 2, and the increase of the latter should increase the absorptive capacity of the intestine.

.

 The Use of DPP-4 Inhibitors in Short Bowel Syndrome@highlight

The inhibition of Dipeptidyl peptidase-4 should increase the concentration of glucagone-like peptide 1 and 2, and the increase of the latter should increase the absorptive capacity of the intestine.

